Pronutria Biosciences Lands $42,500,000 New Financing

  • Feed Type
  • Date
    2/24/2016
  • Company Name
    Pronutria Biosciences
  • Mailing Address
    840 Memorial Drive 3rd Floor Cambridge, MA 02139 USA
  • Company Description
    Pronutria is pioneering first-in-class medicines to treat or cure serious conditions where cell homeostasis has been disrupted by amino acid imbalances. We achieve this by using a systems pharmacology approach to deliver disease-specific amino acid compositions that improve the function of biological pathways and regenerate health.
  • Website
    http://www.pronutriabio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $42,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The proceeds from this financing will help to fund the ongoing rapid transformation of the company from a unique and revolutionary platform to late stage clinical candidates in several disease indications.
  • M&A Terms
  • Venture Investor
    Nestlé Health Science

Trending on Xconomy